Norbornyl Cations of Group 14 Elements by Thomas Müller (3554)

“…The norbornyl cations <b>4a </b>(E = Si, R = Me), <b>4e</b> (E = Si, R = Et), <b>4f</b> (E = Si, R = Bu), <b>4g</b> (E = Ge, R = Bu), <b>4h</b> (E = Sn, R = Bu), and <b>4i</b> (E = Pb, R = Et) have been identified by their characteristic NMR chemical shifts (<b>4a,e,f</b>, δ(²⁹Si) = 80−87, δ(¹³C)(CH) = 149.6−150.6;<b> 4g</b>, δ(¹³C)(CH) = 144.8;<b> 4h</b>, δ(¹¹⁹Sn) = 334, δ(¹³C)(CH) = 141.5; <b>4i</b>, δ(²⁰⁷Pb) = 1049, δ(¹³C)(CH) = 138). …”

K13 partially co-localizes with vesicular transport proteins and sites adjacent to cytostomes. by Nina F. Gnädig (8735760)

Three-dimensional diagrams of the influence of the joint bending stiffness on the effective length correction factor. by Jinfeng Dong (1293039)

Three-dimensional diagrams of the influence of wall thickness size of vertical pole section on the effective length correction factor. by Jinfeng Dong (1293039)

Correlation between the ‘true’ (based on 20M RPS data) and low sequencing depth based FF estimates. by Priit Paluoja (6927959)

Comparison of 20M RPS fetal fraction estimates with the estimates on lower coverages. by Priit Paluoja (6927959)

Three-dimensional diagrams of the influence of outer diameter size of vertical pole section on the effective length correction factor. by Jinfeng Dong (1293039)

Reduction of ETV1 is Identified as a Prominent Feature of Age-Related Cataract by Xiaodi Qiu (330532)

Temporal Patterns of Medications Dispensed to Children and Adolescents in a National Insured Population by Karen L. Olson (149953)

“…This rate decreased somewhat over time, primarily because proportionally fewer children were dispensed a single medication. …”

Artificial enhancer constructs reveal a tandem-<i>like</i> structure. by Maximilian Haeussler (86348)

“…The element has been divided into five parts (a, b, c, d, e). (ab) fragment is in dark blue, (d) in light blue with blue outline, (e) in light blue. …”

Image1_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG by Panayiota Christodoulou (13832038)

“…As attested by flow cytometry, combination treatment was associated with decreased the percentage of late apoptotic cells compared with monotherapy (fold-change of decrease = 1.6 and 4.5 for 15 and 20 μΜ, respectively). …”

A Preorganized Ditopic Borane as Highly Efficient One- or Two-Electron Trap by Alexander Hübner (1635205)

“…EPR spectroscopy on Li­[<b>1</b>] reveals hyperfine coupling of the unpaired electron to two magnetically equivalent boron nuclei (<i>a</i>(¹¹B) = 5.1 ± 0.1 G, <i>a</i>(¹⁰B) = 1.7 ± 0.2 G). …”

Image2_Amygdalin as a chemoprotective agent in co-treatment with cisplatin.PNG by Panayiota Christodoulou (13832038)

“…As attested by flow cytometry, combination treatment was associated with decreased the percentage of late apoptotic cells compared with monotherapy (fold-change of decrease = 1.6 and 4.5 for 15 and 20 μΜ, respectively). …”

Polyamine depletion reroutes energy production to glycolysis. by Yazmin E. Cruz-Pulido (20285238)

Identification of Yhp1/Yox1-regulated genes. by Michelle M. Conti (13514386)

Impact of mepolizumab in patients with high-burden severe asthma within a managed care population by Njira L. Lugogo (13119569)

“…Of the 264 patients with ≥1 OCS claim during baseline, 191 (72.3%) showed a decrease in mean daily OCS use by ≥50% in 117 patients (61.3%). …”

Immunocytochemical staining of CS stub in expanded SCE-UCBCs. by Keiko Nakanishi (11998917)

Interaction plots for probability of in-hospital death by management group and spleen severity in patients (n = 7210) with AIS≤ = 2 in head/neck, face, chest, extremity, and extern... by Randeep S. Jawa (20489181)

Examples of circles with random bidisperse distributions of diameters with (a) CoV <i>δ</i> = 0.4, skewness <i>D</i>₃ = −1; (b) <i>δ</i> = 0.4, <i>D</i>₃ = 0;... by David J. Meer (17941182)

Characterization of JTA009, a novel anti-human ICOS mAb by Manabu Kawamoto (18939)

“…</p><p>Published online 22 Mar 2006</p><p>PMCID:PMC1526621.</p><p></p> JTA009, a fully human anti-human ICOS mAb, has greater avidity than SA12. …”